NO994900L - Forbindelser - Google Patents

Forbindelser

Info

Publication number
NO994900L
NO994900L NO994900A NO994900A NO994900L NO 994900 L NO994900 L NO 994900L NO 994900 A NO994900 A NO 994900A NO 994900 A NO994900 A NO 994900A NO 994900 L NO994900 L NO 994900L
Authority
NO
Norway
Prior art keywords
compounds
aromatic ring
membered heterocyclic
heterocyclic aromatic
ring containing
Prior art date
Application number
NO994900A
Other languages
English (en)
Norwegian (no)
Other versions
NO994900D0 (no
Inventor
Thomas Mcinally
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO994900D0 publication Critical patent/NO994900D0/no
Publication of NO994900L publication Critical patent/NO994900L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO994900A 1997-04-09 1999-10-08 Forbindelser NO994900L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701304A SE9701304D0 (sv) 1997-04-09 1997-04-09 Compounds
PCT/SE1998/000641 WO1998045294A1 (en) 1997-04-09 1998-04-07 Compounds

Publications (2)

Publication Number Publication Date
NO994900D0 NO994900D0 (no) 1999-10-08
NO994900L true NO994900L (no) 1999-11-19

Family

ID=20406499

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994900A NO994900L (no) 1997-04-09 1999-10-08 Forbindelser

Country Status (21)

Country Link
US (1) US6303613B1 (xx)
EP (1) EP0973772A1 (xx)
JP (1) JP2001519805A (xx)
KR (1) KR20010006143A (xx)
CN (1) CN1259131A (xx)
AU (1) AU7091098A (xx)
BR (1) BR9807950A (xx)
CA (1) CA2285388A1 (xx)
CZ (1) CZ355199A3 (xx)
EE (1) EE9900448A (xx)
HU (1) HUP0001865A2 (xx)
ID (1) ID23861A (xx)
IL (1) IL132085A0 (xx)
IS (1) IS5208A (xx)
NO (1) NO994900L (xx)
NZ (1) NZ338006A (xx)
PL (1) PL336141A1 (xx)
SE (1) SE9701304D0 (xx)
SK (1) SK128999A3 (xx)
TR (1) TR199902495T2 (xx)
WO (1) WO1998045294A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
AU2001282886A1 (en) * 2000-07-13 2002-01-30 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
ES2290157T3 (es) 2000-07-20 2008-02-16 Lauras As Uso de inhibidores de cox-2 como inmunoestimulantes en el tratamiento de vih o sida.
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
WO2003088958A2 (en) * 2002-04-18 2003-10-30 Pharmacia Corporation Combinations of cox-2 inhibitors and other agents for the treatment of parkinson’s disease
AU2003226379A1 (en) * 2002-04-18 2003-11-03 Pharmacia Corporation Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
AU2003260033A1 (en) * 2002-08-29 2004-03-19 Schering Aktiengesellschaft Methods of treating acute respiratory distress syndrome
EP1558081A4 (en) * 2003-01-13 2006-06-14 Dynogen Pharmaceuticals Inc METHOD OF TREATING FUNCTIONAL INTESTINAL DISORDERS
EP1626961B1 (en) * 2003-05-17 2011-11-02 Korea Research Institute of Bioscience and Biotechnology Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
DE102005024012A1 (de) * 2005-05-20 2006-11-23 Grünenthal GmbH Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
JP4850914B2 (ja) * 2005-09-01 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３およびｐ２ｘ２／３モジュレーターとしてのジアミノピリミジン
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
AU2009260899B2 (en) 2008-06-18 2012-02-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403152A (en) 1967-03-20 1968-09-24 Ciba Geigy Corp 1-aryl-4-imino-1, 2, 3, 4-tetrahydroquinazolines
US3483205A (en) 1967-12-22 1969-12-09 Ciba Geigy Corp Bicyclic tetrahydropyrimidines
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination

Also Published As

Publication number Publication date
ID23861A (id) 2000-05-25
EP0973772A1 (en) 2000-01-26
SE9701304D0 (sv) 1997-04-09
WO1998045294A1 (en) 1998-10-15
AU7091098A (en) 1998-10-30
IL132085A0 (en) 2001-03-19
KR20010006143A (ko) 2001-01-26
EE9900448A (et) 2000-04-17
JP2001519805A (ja) 2001-10-23
NZ338006A (en) 2001-04-27
CN1259131A (zh) 2000-07-05
PL336141A1 (en) 2000-06-05
SK128999A3 (en) 2000-05-16
US6303613B1 (en) 2001-10-16
IS5208A (is) 1999-10-05
BR9807950A (pt) 2000-03-08
TR199902495T2 (xx) 2000-07-21
CZ355199A3 (cs) 2000-03-15
CA2285388A1 (en) 1998-10-15
NO994900D0 (no) 1999-10-08
MX9909188A (en) 2001-07-01
HUP0001865A2 (hu) 2001-01-29

Similar Documents

Publication Publication Date Title
NO994900L (no) Forbindelser
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
WO2002090332A3 (en) Novel aeylheteroalkylaminε derivatives
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
HUP0004559A1 (hu) Ciklinfüggő kinázok aminotiazol inhibitorai, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO324228B1 (no) 4-amino-5-cyano-2-anilino-pyrimidinderivater og deres anvendelse og fremgangsmate for fremstilling, samt farmasoytisk sammensetning
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20024014D0 (no) Ny bruk av fenylheteroalkylaminderivater
NO20015172L (no) 1-metyl-erytromycin-derivater
SE9803518D0 (sv) Novel compounds
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
NO20065873L (no) 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner
SE9803773D0 (sv) Compounds
SE0302756D0 (sv) Novel Compounds
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO995007L (no) Forbindelser
NO982072L (no) Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase
NO996544L (no) Forbindelser
NO20053805L (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
AU2001234314A1 (en) Novel phenylheteroalkylamine derivatives
DE60210981D1 (de) Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase
NO20013921L (no) Heterocykliske derivater som inhibitorer av faktor Xa
SE9904676D0 (sv) Novel compounds
WO2003011210A3 (en) Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application